Atbin Djamshidian1, Sean S O'Sullivan2, Alessandro Tomassini3, Thomas Foltynie3, Patricia Limousin3, Iciar Aviles-Olmos3, Thomas T Warner4, Andrew J Lees4, Bruno B Averbeck5. 1. Department of Molecular Neuroscience and Reta Lila Weston Institute for Neurological Studies, University of London, London, UK Department of Neurology, University Clinic Innsbruck, Tyrol, Austria. 2. Cork University Hospital, University College Cork, Cork, Ireland. 3. Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, London, UK. 4. Department of Molecular Neuroscience and Reta Lila Weston Institute for Neurological Studies, University of London, London, UK. 5. Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Abstract
BACKGROUND: It has been suggested that all patients with Parkinson's disease (PD) who undergo functional neurosurgery have difficulties in slowing down in high conflict tasks. However, it is unclear whether concomitant dopaminergic medication is responsible for this impairment. OBJECTIVE: To assess perceptual decision making in PD patients with bilateral deep brain stimulation. METHODS: We tested 27 PD patients with bilateral deep brain stimulation on a task in which participants had to filter task relevant information from background noise. Thirteen patients were treated with Levodopa monotherapy and 14 patients were treated with Levodopa in combination with a dopamine agonist. RESULTS were compared to healthy matched controls. RESULTS: We found that all PD patients who were treated with a dopamine agonist made faster decisions than controls and PD patients who were not exposed to a dopamine agonist. Further, all patients made more errors than controls, but there was no difference between the two patient groups. CONCLUSIONS: Our results suggest that dopamine agonist therapy rather than deep brain stimulation is likely responsible for the inability to slow down in high conflict situations in PD. These results further strengthen the need to reduce dopamine agonists in PD patients undergoing functional neurosurgery in order to prevent them making inadvisable decisions.
BACKGROUND: It has been suggested that all patients with Parkinson's disease (PD) who undergo functional neurosurgery have difficulties in slowing down in high conflict tasks. However, it is unclear whether concomitant dopaminergic medication is responsible for this impairment. OBJECTIVE: To assess perceptual decision making in PDpatients with bilateral deep brain stimulation. METHODS: We tested 27 PDpatients with bilateral deep brain stimulation on a task in which participants had to filter task relevant information from background noise. Thirteen patients were treated with Levodopa monotherapy and 14 patients were treated with Levodopa in combination with a dopamine agonist. RESULTS were compared to healthy matched controls. RESULTS: We found that all PDpatients who were treated with a dopamine agonist made faster decisions than controls and PDpatients who were not exposed to a dopamine agonist. Further, all patients made more errors than controls, but there was no difference between the two patient groups. CONCLUSIONS: Our results suggest that dopamine agonist therapy rather than deep brain stimulation is likely responsible for the inability to slow down in high conflict situations in PD. These results further strengthen the need to reduce dopamine agonists in PDpatients undergoing functional neurosurgery in order to prevent them making inadvisable decisions.
Entities:
Keywords:
Deep brain stimulation; Parkinson's disease; dopamine agonists; perceptual decision making
Authors: James F Cavanagh; Thomas V Wiecki; Michael X Cohen; Christina M Figueroa; Johan Samanta; Scott J Sherman; Michael J Frank Journal: Nat Neurosci Date: 2011-09-25 Impact factor: 24.884
Authors: Scott A Wylie; K Richard Ridderinkhof; William J Elias; Robert C Frysinger; Theodore R Bashore; Kara E Downs; Nelleke C van Wouwe; Wery P M van den Wildenberg Journal: Brain Date: 2010-09-22 Impact factor: 13.501
Authors: Shen-Yang Lim; Sean S O'Sullivan; Katya Kotschet; David A Gallagher; Cameron Lacey; Andrew D Lawrence; Andrew J Lees; Dudley J O'Sullivan; Richard F Peppard; Julian P Rodrigues; Anette Schrag; Paul Silberstein; Stephen Tisch; Andrew H Evans Journal: J Clin Neurosci Date: 2009-06-23 Impact factor: 1.961
Authors: Sarah J Moum; Catherine C Price; Natlada Limotai; Genko Oyama; Herbert Ward; Charles Jacobson; Kelly D Foote; Michael S Okun Journal: PLoS One Date: 2012-01-25 Impact factor: 3.240
Authors: Elizabeth J Coulthard; Rafal Bogacz; Shazia Javed; Lucy K Mooney; Gillian Murphy; Sophie Keeley; Alan L Whone Journal: Brain Date: 2012-10-31 Impact factor: 13.501
Authors: Flavio Henrique de Rezende Costa; Bruno Averbeck; Sean S O'Sullivan; Maurice Borges Vincent; Ana Lucia Rosso; Andrew J Lees; Atbin Djamshidian Journal: Neuropsychologia Date: 2016-03-05 Impact factor: 3.139
Authors: Beatrice Heim; Marie-Theres Pertl; Ambra Stefani; Anna Heidbreder; Laura Zamarian; Elisabeth Brandauer; Bruno Averbeck; Margarete Delazer; Klaus Seppi; Birgit Högl; Werner Poewe; Atbin Djamshidian Journal: Ann Clin Transl Neurol Date: 2018-01-30 Impact factor: 4.511
Authors: Paula Banca; Martin D Vestergaard; Vladan Rankov; Kwangyeol Baek; Simon Mitchell; Tatyana Lapa; Miguel Castelo-Branco; Valerie Voon Journal: Neuropsychopharmacology Date: 2015-03-13 Impact factor: 7.853